Skip to main content
. Author manuscript; available in PMC: 2017 Dec 26.
Published in final edited form as: Oncogene. 2017 Jun 26;36(43):5939–5947. doi: 10.1038/onc.2017.197

Figure 8.

Figure 8

A proposed model for the mechanism by which MKP-1 inactivates JNK1/2-mediated PARP-1 phosphorylation, ubiquitination and degradation, which leads to cisplatin resistance.